This week an advisory panel to the Food and Drug Administration voted unanimously to recommend the approval of the first-ever rapid, over-the-counter, completely in-home HIV test. Though the FDA has approved other HIV test kits designed for at-home use in the past, those tests require a blood sample that must be sent in to a laboratory for development. The newly considered test kit – called the OraQuick In-Home HIV Test – simply requires a mouth swab and a 20-minute wait for results.
It’s estimated that approximately one-fifth of the 1.2 million HIV carriers in the United States are unaware of their infection, and advocates of OraQuick say the test would provide a new and powerful attack against the American HIV epidemic.
Art Caplan, a regular guest on The Takeaway, discusses whether this test kit is a game-changer in the fight against HIV/AIDS and whether the kit’s benefits outweigh the ethical holes facing home-testing. Caplan is a professor of bioethics at the University of Pennsylvania.
The story you just read is available to read for free because thousands of listeners and readers like you generously support our nonprofit newsroom. Every day, the reporters and producers at The World are hard at work bringing you human-centered news from across the globe. But we can’t do it without you: We need your support to ensure we can continue this work for another year.
When you make a gift of $10 or more a month, we’ll invite you to a virtual behind-the-scenes tour of our newsroom to thank you for being with The World.